logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-10. Age distribution by primary drug of clients entering treatment — EU overall summary in 2006 [see all tables in this series...]

Part (i) Percentage distribution of new outpatient clients by age group for each primary drug

Substance<1515–1920–2425–2930–3435–3940–44Mean ageAge known (base)Age not known
Opioids0.15.520.222.019.615.39.97.331.4458612277
Cocaine0.16.920.624.620.513.88.25.230.430813278
Stimulants1.523.629.518.712.58.23.82.225.9534023
Hypnotics and sedatives0.68.311.411.814.513.310.729.335.5254737
Hallucinogens1.324.830.924.310.44.31.72.224.92303
Volatile substances32.141.910.55.03.64.52.20.219.34181
Cannabis 3.833.030.016.07.84.62.52.223.840255458
Other substances 2.210.017.715.215.211.98.919.032.4196480
Total1.515.623.520.315.611.16.95.628.61274283157

Notes:

 The countries supplying data are: 

 BG, CZ, DK, DE, IE, EL, ES, FR, IT, CY, LV, LT, HU, MT, NL, AT, PT, SK, FI, SE, UK. 

 Last data available from Spain refer to year of treatment 2005. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-102 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2007 — Table TDI outpatient and inpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Monday, 14 July 2008